Latest Australian Securities News

Classic Minerals has engaged AFDC to conduct a strategic review and is raising A$3 million to advance exploration at its Forrestania gold project and support its ASX relisting efforts.

Variscan Mines has obtained Supreme Court approval to rectify a delayed cleansing notice related to a major share issue, paving the way for trading to resume. The company has also committed to strengthening its compliance procedures following the oversight.

H&G High Conviction Limited has been suspended from ASX trading due to failing to meet operational requirements, raising questions about its future as a listed entity.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.

Diversified United Investment Limited (DUI) has registered its Scheme Booklet with ASIC, proposing a merger with Australian United Investment Company Limited (AUI). The Independent Expert concludes the merger is in the best interests of DUI shareholders, with directors unanimously recommending a vote in favour.

Findi Limited has extended the closing date of its offer to 19 March 2026 and updated details following a $25 million institutional placement. The company’s share capital structure and financial position have been revised, with key changes including director participation and lead manager incentives.

Electro Optic Systems Holdings Limited (EOS) has responded to ASX concerns over insufficient details in its December 2025 announcement about a major US$80 million high energy laser contract, prompting a review and update of its continuous disclosure policy.

Manhattan Gold Limited has clarified recent share price and volume spikes, attributing them to strategic corporate communications and a fresh investor research report.

Immutep Limited has voluntarily suspended trading of its shares on the ASX pending the release of a key announcement regarding the interim futility analysis of its TACTI-004 Phase III trial. The suspension underscores the market’s anticipation of potentially pivotal clinical trial results.

Variscan Mines Limited has voluntarily suspended trading on the ASX pending a Supreme Court decision related to a regulatory compliance issue with a past share issue. The suspension highlights ongoing legal scrutiny and investor uncertainty.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.